UnitedHealth Group (UNH) Price Target Raised to $268.00
UnitedHealth Group (NYSE:UNH) had its price target boosted by equities researchers at Citigroup from $235.00 to $268.00 in a research note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Citigroup’s price objective would suggest a potential upside of 14.10% from the company’s previous close.
A number of other equities research analysts also recently weighed in on UNH. Royal Bank of Canada raised their price objective on UnitedHealth Group from $269.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday. BMO Capital Markets raised their price objective on UnitedHealth Group from $14.50 to $275.00 and gave the company an “outperform” rating in a research report on Wednesday. Piper Jaffray Companies reaffirmed a “buy” rating and set a $259.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Cantor Fitzgerald reaffirmed a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a research report on Tuesday. Finally, Evercore ISI reaffirmed an “outperform” rating and set a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Three research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $233.98.
Shares of UnitedHealth Group (UNH) traded up $1.99 during mid-day trading on Wednesday, reaching $234.89. The company had a trading volume of 1,485,574 shares, compared to its average volume of 2,930,000. UnitedHealth Group has a 12 month low of $156.09 and a 12 month high of $236.92. The company has a market capitalization of $227,020.00, a P/E ratio of 21.93, a P/E/G ratio of 1.53 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter last year, the company earned $2.11 earnings per share. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. sell-side analysts predict that UnitedHealth Group will post 9.99 EPS for the current fiscal year.
In other news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,630 shares of company stock valued at $7,669,416. Company insiders own 0.89% of the company’s stock.
A number of institutional investors have recently bought and sold shares of the stock. National Pension Service grew its holdings in UnitedHealth Group by 3.6% during the fourth quarter. National Pension Service now owns 751,873 shares of the healthcare conglomerate’s stock worth $165,758,000 after acquiring an additional 26,363 shares during the period. Asset Dedication LLC grew its holdings in UnitedHealth Group by 13.6% during the fourth quarter. Asset Dedication LLC now owns 9,692 shares of the healthcare conglomerate’s stock worth $2,137,000 after acquiring an additional 1,164 shares during the period. Wasatch Advisors Inc. grew its holdings in UnitedHealth Group by 191.0% during the fourth quarter. Wasatch Advisors Inc. now owns 3,390 shares of the healthcare conglomerate’s stock worth $747,000 after acquiring an additional 2,225 shares during the period. Davis R M Inc. grew its holdings in UnitedHealth Group by 15.9% during the fourth quarter. Davis R M Inc. now owns 4,158 shares of the healthcare conglomerate’s stock worth $917,000 after acquiring an additional 571 shares during the period. Finally, Strategic Advisors LLC grew its holdings in UnitedHealth Group by 12.4% during the fourth quarter. Strategic Advisors LLC now owns 2,873 shares of the healthcare conglomerate’s stock worth $633,000 after acquiring an additional 317 shares during the period. 86.09% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/unitedhealth-group-unh-price-target-raised-to-268-00/1810740.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.